{
    "2021-03-17": [
        [
            {
                "time": "",
                "original_text": "A股史上首次蓝筹股泡沫破裂，6成私募反对抄底",
                "features": {
                    "keywords": [
                        "蓝筹股",
                        "泡沫破裂",
                        "私募",
                        "抄底"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "蓝筹股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "反弹！调整这么多，能买抱团股吗？",
                "features": {
                    "keywords": [
                        "反弹",
                        "调整",
                        "抱团股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "抱团股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券----医药行业2021年一季度业绩前瞻：CXO、器械、药店等有望延续高增长【行业研究】",
                "features": {
                    "keywords": [
                        "医药行业",
                        "CXO",
                        "器械",
                        "药店",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "近3000家上市公司参与2020年度投资者关系工作调研（附2018、2019年度报告）",
                "features": {
                    "keywords": [
                        "上市公司",
                        "投资者关系",
                        "调研"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "29家公司高管出手增持动用资金3.71亿元",
                "features": {
                    "keywords": [
                        "公司高管",
                        "增持",
                        "资金"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药板块大幅回调 看好中长期发展前景",
                "features": {
                    "keywords": [
                        "医药板块",
                        "回调",
                        "中长期发展"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "又见中欧基金新基发行！葛兰光环黯淡产品均陷巨大回撤，能否担纲重任？",
                "features": {
                    "keywords": [
                        "中欧基金",
                        "新基发行",
                        "葛兰",
                        "回撤"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}